Actylis Acquires Pharm-Rx
October 7, 2024
Actylis has acquired Pharm-Rx, a Saddle Brook, New Jersey-based supplier of specialty ingredients for the vitamin, mineral and supplement (VMS), OTC and pharmaceutical markets. The deal expands Actylis' nutrition and OTC capabilities and supplier partnerships; Pharm-Rx will continue to operate under its brand and Mark Bostel will become President, Global Nutrition and OTC for Actylis. Financial terms were not disclosed.
- Buyers
- Actylis
- Targets
- Pharm-Rx
- Industry
- Pharmaceuticals
- Location
- New Jersey, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
New Mountain-backed Actylis Integrates Aceto and 10 Specialty Ingredients Businesses
September 26, 2022
Manufacturing
New Mountain Capital’s new platform Actylis launched by combining Aceto and ten acquired specialty ingredient manufacturers and sourcing firms into a single global company. The combined business unites GMP and non‑GMP manufacturing, R&D, quality and sourcing capabilities across multiple countries to supply critical raw materials for pharmaceuticals, nutrition, cosmetics, agriculture and specialty chemicals.
-
Agno Pharma Acquires Actylis Eugene (Legacy Cascade Chemistry) in Eugene, Oregon
January 15, 2026
Pharmaceuticals
Agno Pharma has acquired Actylis Eugene, the legacy Cascade Chemistry manufacturing asset in Eugene, Oregon, expanding Agno's U.S. cGMP API development and manufacturing footprint. The site includes a 16,000 sq. ft. R&D lab and a newly constructed 30,000 sq. ft. GMP manufacturing facility, enhancing Agno's capabilities to support biotech and pharmaceutical clients from early-phase through commercial API production.
-
AmerisourceBergen Acquires PharmaLex from AUCTUS in €1.28bn Transaction
December 31, 2022
Healthcare Services
AmerisourceBergen Corporation acquired a majority stake in PharmaLex from funds advised by AUCTUS Capital Partners AG in a transaction that closed at year-end 2022 for approximately EUR 1.28 billion. PharmaLex, a Germany-headquartered provider of regulatory, clinical development and pharmacovigilance services to the life sciences industry, was grown under AUCTUS through a buy-and-build program of 38 add-ons and will expand AmerisourceBergen's global pharmaceutical solutions.
-
22nd Century Group Acquires RX Pharmatech Ltd
January 24, 2023
Food & Beverage
22nd Century Group, through its GVB Biopharma business, acquired UK-based RX Pharmatech Ltd, a distributor of cannabinoid/CBD products and holder of numerous U.K. novel food applications. The deal includes $650,000 up-front in cash and stock plus a three-year equity earn-out tied to revenue milestones and aims to strengthen 22nd Century's access and distribution in the U.K. and EU consumer CBD market.
-
Medvantx Acquires RxS
July 8, 2025
Healthcare Services
Medvantx, a San Diego-based pharmacy services provider, has acquired RxS, a multichannel sample management and accountability solutions company headquartered in Manalapan, New Jersey. The acquisition integrates RxS’s sampling and engagement technology with Medvantx’s patient access, PAP fulfillment, telehealth and distribution services to broaden capability and accelerate access for pharmaceutical and device manufacturers.
-
GoodRx Acquires vitaCare
April 14, 2022
Healthcare Services
GoodRx has completed its acquisition of vitaCare for $150 million in cash plus up to $7 million contingent on vitaCare's 2023 performance. The deal adds a tech-enabled pharmacy services platform to GoodRx's capabilities, expanding its Pharma Manufacturer Solutions and enabling more efficient patient access, fulfillment, and adherence for brand medications.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.